New York’s New Biomarker Testing Insurance Coverage: Your Rights Explained
Philip Crowley
July 25, 2023
Improvements to New York Health Insurance: Biomarker Testing Testing for biomarkers in patients is the state of the art in
Improvements to New York Health Insurance: Biomarker Testing Testing for biomarkers in patients is the state of the art in
Today’s cancer care is incomplete. Cancer affects not only the body of the patient but also his or her emotional
The State of New Jersey has an affinity for life sciences innovators. That’s the message of last week’s meeting sponsored
This week boasted announcement of a monumental achievement in the fight against Parkinson’s disease. Parkinson’s disease is a progressive neurodegenerative
Last week I had the opportunity to attend the BioMedical Engineering Day at Stevens Institute of Technology in Hoboken, New Jersey. It
Global Cyber Threats Are Now Targeting Medical Devices A hostile, controlling government launches a coordinated ransomware attack on computers across
Demystifying the FDA Investigational Device Exemption (IDE) Process The journey to bring a new medical device to market is a
Why the IND Process Matters Drug sponsors face a long and winding road from discovery to market. A critical step
Patents For Humanity Program Improvement Act The Patents for Humanity Program Improvement Act, H.R. 7259, was introduced on June 18th,
According to the National Institutes of Health (NIH), there are over 7,000 diseases classified as rare, affecting an estimated 25-30 million Americans.
What You Need to Know to Get Approved Bringing a new drug therapy or medical device to market is a
No business wants unexpected liabilities. People across the country are returning to work in high-contact and other industries. It’s not
Health care needs real competition. So say two Harvard faculty members based on research and experience discussed in a Harvard